Verity Pharmaceuticals presents news that is not only specific to our corporation but also includes important information that is relevant to the therapeutic areas represented by our products.
FDA-approved antibiotic with life-saving potential launches in Puerto Rico – March 14, 2022
Verity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto Rico – February 16, 2022
Verity Pharmaceuticals and Acerus Pharmaceuticals form commercial agreement for the promotion of Natesto® in Puerto Rico – January 10, 2022
Debiopharm partners with Verity Pharmaceuticals for the exclusive U.S. commercialization of Trelstar® for prostate cancer – June 9, 2020